Evidence map›Paper›PMID 28768911›Full record

ArticleJCI insight2017

A CCR2+ myeloid cell niche required for pancreatic β cell growth.

Kristin Mussar, Stephanie Pardike, Tobias M Hohl, Gary Hardiman, Vincenzo Cirulli, Laura Crisa

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Islet Regeneration: Endogenous and Exogenous Approaches.International journal of molecular sciences · 2021
    Review
  9. Review
  10. Review
  11. Immune regulation of islet homeostasis and adaptation.Journal of molecular cell biology · 2020
    Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kristin MussarDepartment of Medicine and Institute of Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington, USA.
Stephanie PardikeDepartment of Medicine and Institute of Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington, USA.
Tobias M HohlDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Gary HardimanDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Vincenzo CirulliDepartment of Medicine and Institute of Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington, USA.
Laura CrisaDepartment of Medicine and Institute of Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington, USA.
Medical University of South Carolina · USMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Elisa de Stanchina · 1985 to 2026
$347.4M
Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jian Ouyang · 2009 to 2026
$42.7M
Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Julie Mathieu · 1986 to 2026
$41.4M
INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUSR01AI093808 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI HOHL, TOBIAS M · 2011 to 2020
$4.9M
INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUSR37AI093808 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI TOBIAS M HOHL · 2021 to 2026
$4.2M
Myeloid cells in tissue growth and regenerationR01DK114693 · NIDDK · UNIVERSITY OF WASHINGTON · PI CRISA, LAURA · 2018 to 2021
$1.8M
Integrin-linked kinase in pancreas developmentR01DK103711 · NIDDK · UNIVERSITY OF WASHINGTON · PI CIRULLI, VINCENZINO · 2016 to 2019
$1.7M
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA138313NIAID NIH HHS R01 AI093808NIAID NIH HHS R37 AI093808NIDDK NIH HHS P30 DK017047NIDDK NIH HHS R01 DK103711NIDDK NIH HHS R01 DK114693
6 · The paper itself

Abstract

Organ-specific patterns of myeloid cells may contribute tissue-specific growth and/or regenerative potentials. The perinatal stage of pancreas development marks a time characterized by maximal proliferation of pancreatic islets, ensuring the maintenance of glucose homeostasis throughout life. Ontogenically distinct CX3CR1+ and CCR2+ macrophage populations have been reported in the adult pancreas, but their functional contribution to islet cell growth at birth remains unknown. Here, we uncovered a temporally restricted requirement for CCR2+ myeloid cells in the perinatal proliferation of the endocrine pancreatic epithelium. CCR2+ macrophages are transiently enriched over CX3CR1+ subsets in the neonatal pancreas through both local expansion and recruitment of immature precursors. Using CCR2-specific depletion models, we show that loss of this myeloid population leads to a striking reduction in β cell proliferation, dysfunctional islet phenotypes, and glucose intolerance in newborns. Replenishment of pancreatic CCR2+ myeloid compartments by adoptive transfer rescues these defects. Gene profiling identifies pancreatic CCR2+ myeloid cells as a prominent source of IGF2, which contributes to IGF1R-mediated islet proliferation. These findings uncover proproliferative functions of CCR2+ myeloid subsets and identify myeloid-dependent regulation of IGF signaling as a local cue supporting pancreatic proliferation.

Indexed as

DevelopmentEndocrinology

Identifiers

PMID28768911
PMCPMC5543911
OpenAlexW2739924830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.